摘要
观察了４７例癌患者和１３例健康人的ＮＫ细胞、内源性ＬＡＫ细胞对靶细胞的杀伤活性及ＮＫ细胞计数。结果表明，癌患者该３项指标均显著低于对照组（Ｐ＜０．００１），尤以晚期癌症和发生远处转移患者的降低为著。不同种类的癌和有无淋巴结转移的患者之间该３项指标无显著性差异。使用ＭＰＳ免疫治疗２周，可显著提高患者的上述３项指标（Ｐ＜０．００１、Ｐ＜０．００１、Ｐ＜０．０５）。
The NK and endogenous LAK activity and the numbers of NK cell were observed in 47 cancer patients and in 13 healthy volunteers. The results revealed that the levels of the three indications were significantly lower in the patients than in the normal controled group(P<0. 001) and the decline were conspicuous in the patients with late stage cancer and distant metastases. Treatment by mycobacterial polysaccharides (MPS) for two weeks has enhanced the levels of these indications in the patients after operation.
出处
《首都医科大学学报》
CAS
1996年第3期193-196,共4页
Journal of Capital Medical University
